| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 27.11.23 | Fusion Fuel Green Public Limited Company: Fusion Fuel Green Announces Strategic Tranched Financing from Belike Nominees Pty Ltd., a Macquarie Group Company | 14 | GlobeNewswire (Europe) | DUBLIN, Ireland, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Fusion Fuel Green PLC (Nasdaq: HTOO) ("Fusion Fuel" or the "Company"), an emerging leader in the green hydrogen sector, today announced that it has... ► Artikel lesen | |
| 27.11.23 | DÉKUPLE: Business For The First Nine Months Of 2023 | 642 | GlobeNewswire (Europe) | BUSINESS FOR THE FIRST NINE MONTHS OF 2023_____ Net sales: €145.3m (+ 10.7%) Gross margin: €117.3m (+ 10.9%)Robust development of the digital marketing business, with its gross margin up 38.5% Paris... ► Artikel lesen | |
| 27.11.23 | iBio, Inc.: iBio Announces Reverse Stock Split | 383 | GlobeNewswire (Europe) | BRYAN, Texas and SAN DIEGO, Nov. 27, 2023 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) ("iBio" or the "Company") today announced that its Board of Directors has approved a 20-to-1 reverse split of... ► Artikel lesen | |
| 27.11.23 | Calian Group Ltd.: Calian Reports Unaudited Results for the Fourth Quarter and FY23 | 238 | GlobeNewswire (Europe) | (All amounts in release are in Canadian dollars) OTTAWA, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Calian® Group Ltd. (TSX:CGY), a diverse products and services company providing innovative healthcare... ► Artikel lesen | |
| 27.11.23 | First Busey Corporation and Merchants and Manufacturers Bank Corporation to Merge | 207 | GlobeNewswire (Europe) | CHAMPAIGN, Ill. and OAKBROOK TERRACE, Ill., Nov. 27, 2023 (GLOBE NEWSWIRE) -- First Busey Corporation ("Busey") (NASDAQ:BUSE), the holding company for Busey Bank, and Merchants and Manufacturers Bank... ► Artikel lesen | |
| 27.11.23 | 22nd Century Group, Inc: 22nd Century Group Enters into Agreement to Sell Hemp/Cannabis Franchise | 412 | GlobeNewswire (Europe) | BUFFALO, N.Y., Nov. 27, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII) (the "Company" or "22nd Century"), a leading biotechnology company focused on utilizing advanced plant technologies... ► Artikel lesen | |
| 27.11.23 | Ocuphire Pharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | 818 | GlobeNewswire (Europe) | FARMINGTON HILLS, Mich., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing small-molecule... ► Artikel lesen | |
| 27.11.23 | Consolidated Uranium Inc.: Consolidated Uranium and Premier American Uranium Announce Closing of Spin-Out | 236 | GlobeNewswire (Europe) | TORONTO, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Consolidated Uranium Inc. ("CUR", the "Company", or "Consolidated Uranium") (TSXV: CUR) (OTCQX: CURUF) and Premier American Uranium Inc. ("PUR" or "Premier... ► Artikel lesen | |
| 27.11.23 | ACELYRIN, INC. Provides Update on Izokibep Clinical Development Program | 266 | GlobeNewswire (Europe) | LOS ANGELES, Nov. 27, 2023 (GLOBE NEWSWIRE) -- ACELYRIN, INC. (Nasdaq: SLRN), a late-stage clinical biopharma company focused on accelerating the development and delivery of transformative medicines... ► Artikel lesen | |
| 27.11.23 | Madrigal Pharmaceuticals, Inc.: Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | 170 | GlobeNewswire (Europe) | CONSHOHOCKEN, Pa., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a clinical-stage biopharmaceutical company pursuing novel therapeutics for nonalcoholic steatohepatitis... ► Artikel lesen | |
| 27.11.23 | Inari Medical, Inc.: Inari Medical Announces First Patient Enrollment in PEERLESS II Randomized Controlled Trial (RCT) | 163 | GlobeNewswire (Europe) | IRVINE, Calif., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) ("Inari") a medical device company with a mission to treat and transform the lives of patients suffering from venous... ► Artikel lesen | |
| 27.11.23 | AnaptysBio, Inc.: Anaptys Expands Immune Cell Modulator Pipeline with Exclusive License to BDCA2 Modulator Antibody Portfolio from Centessa Pharmaceuticals | 239 | GlobeNewswire (Europe) | Anaptys licenses exclusive global development and commercialization rights to a potential best-in-class BDCA2 modulator portfolioIND filing to support clinical development of ANB101 in autoimmune... ► Artikel lesen | |
| 27.11.23 | Earth Alive Clean Technologies Inc.: Earth Alive Announces 34% Year over Year Sales Increase During its Third Quarter | 174 | GlobeNewswire (Europe) | MONTRÉAL, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Earth Alive Clean Technologies Inc. (TSXV: EAC - "Earth Alive" or the "Company"), a leader in the development, production and distribution of technological... ► Artikel lesen | |
| 27.11.23 | Bitfarms Ltd.: Bitfarms Initiates Transformative Fleet Upgrade that Supports 17 EH/s and 391 MW in 2024 | 833 | GlobeNewswire (Europe) | - Purchases 35,888 Bitmain T21 miners to be delivered and installed in H1 2024 -- Provides Q2 2024 guidance of 310 MW and 12 EH/s at 25 w/TH -- Secures option for an additional 28,000 T21 miners to... ► Artikel lesen | |
| 27.11.23 | Zscaler, Inc.: Zscaler Reports First Quarter Fiscal 2024 Financial Results | 252 | GlobeNewswire (Europe) | First Quarter Highlights Revenue grows 40% year-over-year to $496.7 millionCalculated billings grows 34% year-over-year to $456.6 millionDeferred revenue grows 39% year-over-year to $1,399.5 millionGAAP... ► Artikel lesen | |
| 27.11.23 | Nasdaq, Inc.: Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date November 15, 2023 | 273 | GlobeNewswire (Europe) | NEW YORK, Nov. 27, 2023 (GLOBE NEWSWIRE) -- At the end of the settlement date of November 15, 2023, short interest in 3,169 Nasdaq Global MarketSM securities totaled 10,924,879,396 shares compared... ► Artikel lesen | |
| 27.11.23 | Vaxcyte, Inc.: Vaxcyte Exercises Option and Enters into Manufacturing Rights Agreement with Sutro Biopharma to Obtain Control Over Manufacturing and Development of Cell-Free Extract for its Vaccine Candidates | 174 | GlobeNewswire (Europe) | -- Vaxcyte Obtains Exclusive Rights to Independently Develop and Manufacture Cell-Free Extract, a Key Component of the Company's Pneumococcal Conjugate Vaccine (PCV) Franchise -- -- Manufacturing... ► Artikel lesen | |
| 27.11.23 | NEO Battery Materials Ltd.: NEO Battery Materials Announces Closing of Non-Brokered Private Placement Pursuant to Listed Issuer Financing Exemption | 195 | GlobeNewswire (Europe) | TORONTO, Nov. 27, 2023 (GLOBE NEWSWIRE) -- (TSXV: NBM) (OTCQB: NBMFF) NEO Battery Materials Ltd. ("NEO" or the "Company"), a low-cost silicon anode materials developer that enables longer-running... ► Artikel lesen | |
| 27.11.23 | Locafy Limited: Locafy Reports Fiscal First Quarter 2024 Results | 157 | GlobeNewswire (Europe) | Fiscal First Quarter 2024 Highlighted by Strategic Partnerships, Maintained Gross Margin of 81%, and 53% Year-Over-Year Cost of Sales Decrease Continued Cost-Efficiency Initiatives Help Drive Locafy... ► Artikel lesen | |
| 27.11.23 | Crown Castle Inc.: Crown Castle Issues Statement in Response to Elliott | 142 | GlobeNewswire (Europe) | HOUSTON, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Crown Castle Inc. (NYSE: CCI) ("Crown Castle") today issued the following statement in response to Elliott Investment Management L.P. ("Elliott"): We value... ► Artikel lesen |
Seite:
1 2 3 4 5 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| EVOTEC | 595 |
| BAYER | 393 |
| BYD | 328 |
| NEL | 311 |
| NVIDIA | 288 |
| TESLA | 274 |
| TUI | 274 |
| PLUG POWER | 268 |
| DEUTSCHE BANK | 266 |
| SUPER MICRO COMPUTER | 249 |
| APPLE | 237 |
| RHEINMETALL | 231 |
| RWE | 221 |
| MERCEDES-BENZ | 206 |
| DEUTSCHE LUFTHANSA | 202 |
| AMAZON | 192 |
| BERKSHIRE HATHAWAY | 189 |
| RENK GROUP | 159 |
| VOLKSWAGEN | 159 |
| ALLIANZ | 155 |
| COMMERZBANK | 152 |
| BIONTECH | 150 |
| AIXTRON SE | 149 |
| PAYPAL | 149 |
| BASF | 145 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
